For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.

Scientific Program

FP496

Non Member

Dr.Naresh Babu
Membership No Author Name Email Mobile
3127 Dr.Ashish R Manthalkar ashishmanthalkar@gmail.com 9538585070
Medical Retina

Healing the Hole: The Promise of Platelet-Rich Plasma

Purpose : To compare the safety and efficacy of 25 gauge pars plana vitrectomy (PPV) with platelet rich plasma (PRP) for the treatment of macular hole.
Methods: Pseudophakic patients with idiopathic macular holes with a minimum diameter (MD) of 600–1500 µm were selected (n=30 patients. All underwent 25 gauge PPV with PRP (group B). 
Results: Mean MD was 784.73 ± 120.10 µm, (P = 0.552). Mean base diameter was 1486.90 ± 281.61 µm (P = 0.180). The median presenting best corrected visual acuity (BCVA) was logMAR 0.78 (Range 0.60–1.00)  (P = 0.103). Anatomical closure was achieved in 93.3% (n = 28/30) (P = 0.158). Type 1 closure was achieved in 83.3% (n = 25/30) eyes.Median BCVA at postoperative 3 month was logMAR 0.60 (range 0.48–0.78), (P = 0.312). The average visual improvement was 2.5 early treatment diabetic retinopathy study (ETDRS) lines (P = 0.339). None of the patients developed postoperative exaggerated inflammatory reactions. 
Conclusion: “PRP may transform macular hole surgery from simply closing a defect to biologically promoting healing.”

No Co-Author Selected